NNZ-2591

NNZ-2591 · Neuren Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NNZ-2591, covering 2024-12-09 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome [Phase 3]